343 related articles for article (PubMed ID: 26751053)
1. Phosphocholine-decorated superparamagnetic iron oxide nanoparticles: defining the structure and probing in vivo applications.
Luchini A; Irace C; Santamaria R; Montesarchio D; Heenan RK; Szekely N; Flori A; Menichetti L; Paduano L
Nanoscale; 2016 May; 8(19):10078-86. PubMed ID: 26751053
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
3. Functionalized SPIONs: the surfactant nature modulates the self-assembly and cluster formation.
Luchini A; Heenan RK; Paduano L; Vitiello G
Phys Chem Chem Phys; 2016 Jul; 18(27):18441-9. PubMed ID: 27338137
[TBL] [Abstract][Full Text] [Related]
4. Interaction with Human Serum Proteins Reveals Biocompatibility of Phosphocholine-Functionalized SPIONs and Formation of Albumin-Decorated Nanoparticles.
Russo Krauss I; Picariello A; Vitiello G; De Santis A; Koutsioubas A; Houston JE; Fragneto G; Paduano L
Langmuir; 2020 Aug; 36(30):8777-8791. PubMed ID: 32575987
[TBL] [Abstract][Full Text] [Related]
5. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Superparamagnetic Iron Oxide Based Nanoprobes as Multifunctional Theranostic Agents for Breast Cancer Imaging and Therapy.
Zheng J; Ren W; Chen T; Jin Y; Li A; Yan K; Wu Y; Wu A
Curr Med Chem; 2018; 25(25):3001-3016. PubMed ID: 28685676
[TBL] [Abstract][Full Text] [Related]
7. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
8. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
9. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
10. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
11. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
12. Partial PEGylation of superparamagnetic iron oxide nanoparticles thinly coated with amine-silane as a source of ultrastable tunable nanosystems for biomedical applications.
Cano M; Núñez-Lozano R; Lumbreras R; González-Rodríguez V; Delgado-García A; Jiménez-Hoyuela JM; de la Cueva-Méndez G
Nanoscale; 2017 Jan; 9(2):812-822. PubMed ID: 27982150
[TBL] [Abstract][Full Text] [Related]
13. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
14. Detection of experimental myocardium infarction in rats by MRI using heat shock protein 70 conjugated superparamagnetic iron oxide nanoparticle.
Shevtsov MA; Nikolaev BP; Ryzhov VA; Yakovleva LY; Dobrodumov AV; Marchenko YY; Margulis BA; Pitkin E; Mikhrina AL; Guzhova IV; Multhoff G
Nanomedicine; 2016 Apr; 12(3):611-621. PubMed ID: 26656626
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
16. Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications.
Massironi N; Colombo M; Cosentino C; Fiandra L; Mauri M; Kayal Y; Testa F; Torri G; Urso E; Vismara E; Vlodavsky I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296711
[TBL] [Abstract][Full Text] [Related]
17. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Neuwelt A; Sidhu N; Hu CA; Mlady G; Eberhardt SC; Sillerud LO
AJR Am J Roentgenol; 2015 Mar; 204(3):W302-13. PubMed ID: 25714316
[TBL] [Abstract][Full Text] [Related]
18. Potential use of superparamagnetic iron oxide nanoparticles for in vitro and in vivo bioimaging of human myoblasts.
Wierzbinski KR; Szymanski T; Rozwadowska N; Rybka JD; Zimna A; Zalewski T; Nowicka-Bauer K; Malcher A; Nowaczyk M; Krupinski M; Fiedorowicz M; Bogorodzki P; Grieb P; Giersig M; Kurpisz MK
Sci Rep; 2018 Feb; 8(1):3682. PubMed ID: 29487326
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
